ARC-100 | Interleukin Related interleukin-related.com

Product Name :
ARC-100

Search keywords :
TPI-287

drugId :
null

Target Vo:
Tubulin

Target Vo Short Name :
Tubulin

Moa_Name:
Tubulin inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Cortice Biosciences Inc

Active Company_Name :
Uc San Francisco

Active Indication_Name:
Supranuclear Palsy, Progressive

In Active Indication_Name:
Lymphoma, Non-Hodgkin

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Fremanezumab Cancer
Rad51 Rabbit mAb Autophagy
TrkA+B+C Antibody: TrkA+B+C Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 92 kDa, targeting to TrkA+B+C. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts